Macquarie Group
SYNH

Macquarie Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Macquarie Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,770
Closed -$170K – 1749
2023
Q1 		$170K Buy
4,770
+1,979
+71% +$71.8K ﹤0.01% 1568
2022
Q4 		$102K Sell
2,791
-1,148,781
-100% -$45.4M ﹤0.01% 1645
2022
Q3 		$54.4M Buy
1,151,572
+473,794
+70% +$30.6M 0.07% 398
2022
Q2 		$48.6M Buy
677,778
+326,529
+93% +$23.9M 0.05% 465
2022
Q1 		$28.4K Sell
351,249
-93
-0% -$7.87K 0.02% 677
2021
Q4 		$36.1M Sell
351,342
-9,791
-3% -$940K 0.03% 593
2021
Q3 		$31.6M Buy
361,133
+551
+0.2% +$49.9K 0.03% 639
2021
Q2 		$32.3M Sell
360,582
-3,657
-1% -$309K 0.03% 659
2021
Q1 		$27.6M Buy
364,239
+81,970
+29% +$6.18M 0.04% 460
2020
Q4 		$19.2M Buy
282,269
+216,403
+329% +$13.5M 0.03% 532
2020
Q3 		$3.5M Buy
65,866
+3,610
+6% +$215K 0.01% 905
2020
Q2 		$3.63M Buy
62,256
+1,009
+2% +$54.2K 0.01% 859
2020
Q1 		$2.41M Sell
61,247
-9,515
-13% -$556K 0.01% 871
2019
Q4 		$4.21M Buy
70,762
+5,786
+9% +$311K 0.01% 849
2019
Q3 		$3.46M Buy
64,976
+3,757
+6% +$193K 0.01% 855
2019
Q2 		$3.13M Buy
61,219
+2,302
+4% +$107K 0.01% 894
2019
Q1 		$3.05M Buy
58,917
+760
+1% +$36.8K 0.01% 882
2018
Q4 		$2.29M Buy
58,157
+1,512
+3% +$70.3K ﹤0.01% 936
2018
Q3 		$2.92M Sell
56,645
-1,610
-3% -$78.8K ﹤0.01% 906
2018
Q2 		$2.73M Buy
+58,255
New +$2.41M ﹤0.01% 923
2016
Q3 		– Sell
-118,366
Closed -$4.51M – 1596
2016
Q2 		$4.51M Buy
118,366
+45,229
+62% +$1.99M ﹤0.01% 900
2016
Q1 		$3.01M Buy
+73,137
New +$3.01M 0.01% 841

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Macquarie Group's SYNH Position: Q2 2023 in Review

Macquarie Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 4,770 shares — an estimated $170K sold.

Macquarie Group first reported a position in SYNH in Q1 2016 and held it in 22 quarters. The position peaked at $54.4M in Q3 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Macquarie Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Macquarie Group sold 4,770 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $170K.
  • Macquarie Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 22 quarters.
  • Macquarie Group's Syneos Health, Inc. Class A Common Stock position peaked at $54.4M in Q3 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Macquarie Group's 13F filing for Q2 2023, filed 14 Aug 2023.